Effect of nasal-valve dilation on obstructive sleep apnea.
OBJECTIVE
Nasal-valve dilation reduces nasal resistance and increases air flow. It is possible that this mechanism prevents hypopharyngeal collapse and sleep apneas. We investigated the effect of a plastic device (Nozovent; Prevancure AB; Västra Frölunda, Sweden)-which dilates the nasal valve-on patients with obstructive sleep apnea (OSA).


METHODS
Prospective interventional study.


METHODS
Twenty-six consecutive patients with OSA were included (22 men; mean +/- SD age, 54.8+/-11.3 years; respiratory disturbance index [RDI], 34.4+/-18.5 events/h; body mass index, 31.6+/-5.7 kg/m(2)).


METHODS
The nasal dilator was inserted during sleep into the nares and fitted to exert a dilating force on the nasal valves by means of its elasticity.


METHODS
Polysomnographic studies were performed before and after 1 month of treatment. A responder is defined as one with a reduction in RDI to < 50% of the baseline value and RDI of < or =10 events/h during treatment.


RESULTS
Five patients dropped out. As a result, only 21 patients were analyzed. Four patients responded, and 17 patients were nonresponders. In the whole population, neither the mean values for respiration during sleep nor sleep staging changed significantly with the device.


CONCLUSIONS
The investigated nasal dilator had no effect on sleep-related breathing disorders in patients with moderate to severe OSA. The reduction in nasal resistance does not prevent hypopharyngeal obstruction.
Schönhofer
B
B
Krankenhaus Kloster Grafschaft, Zentrum für Pneumologie, Beatmungs - und Schlafmedizin, Schmallenberg-Grafschaft, Germany. Bernd.Schoenhofer@t-online.de
Franklin
K A
KA
Brünig
H
H
Wehde
H
H
Köhler
D
D
D000403:Airway Resistance; D015992:Body Mass Index; D004106:Dilatation / Q000295:instrumentation*; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009296:Nasal Cavity; D015508:Nasal Obstruction / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D017286:Polysomnography; D011446:Prospective Studies; D020181:Sleep Apnea, Obstructive / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*